MYC plus class IIa HDAC inhibition drives mitochondrial dysfunction in non-small cell lung cancer. - Park J; Chen YY; Cao JJ; An J; Chiu Yen RW; Outen JD; Baylin SB; Topper MJ (Cell reports, 2025)